Orteronel Switch Maintenance Therapy in Metastatic Castration Resistant Prostate Cancer After First-Line Docetaxel: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial (SAKK 08/11). (Q47642783)
Jump to navigation
Jump to search
scientific article published on 25 July 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Orteronel Switch Maintenance Therapy in Metastatic Castration Resistant Prostate Cancer After First-Line Docetaxel: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial (SAKK 08/11). |
scientific article published on 25 July 2016 |
Statements
1 reference
Orteronel Switch Maintenance Therapy in Metastatic Castration Resistant Prostate Cancer After First-Line Docetaxel: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial (SAKK 08/11). (English)
1 reference
Richard Cathomas
1 reference
Michael Mark
1 reference
Ralph Winterhalder
1 reference
Christian Rothermundt
1 reference
Tony Elliott
1 reference
Philippe von Burg
1 reference
Heike Kenner
1 reference
Simona Berardi Vilei
1 reference
Daniel Rauch
1 reference
Enrico Roggero
1 reference
Markus G Mohaupt
1 reference
Jürg Bernhard
1 reference
Gabriela Manetsch
1 reference
Swiss Group for Clinical Cancer Research SAKK
1 reference
25 July 2016
1 reference
1 reference
76
1 reference
16
1 reference
1519-1527
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference